IRIS

No differences in response rate (RR), progression-free survival (PFS), overall survival (OS) and quality of life (QoL) were seen in patients randomly treated with biweekly oxaliplatin plus either fluorouracil/folinic acid or capecitabine.

Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., et al. (2010). Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. ACTA ONCOLOGICA, 49(1), 50-56 [10.3109/02841860903369540].

Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet

ROSELLI, MARIO
2010-01-01

Abstract

No differences in response rate (RR), progression-free survival (PFS), overall survival (OS) and quality of life (QoL) were seen in patients randomly treated with biweekly oxaliplatin plus either fluorouracil/folinic acid or capecitabine.
2010
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/06 - ONCOLOGIA MEDICA
English
Con Impact Factor ISI
Treatment Outcome; Prognosis; Aged, 80 and over; Male; Retrospective Studies; Randomized Controlled Trials as Topic; Middle Aged; Kaplan-Meier Estimate; Colorectal Neoplasms; Female; Disease-Free Survival; Humans; Quality of Life; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Aged; Adult; Health Status Indicators; Multicenter Studies as Topic
Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., et al. (2010). Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. ACTA ONCOLOGICA, 49(1), 50-56 [10.3109/02841860903369540].
Comella, P; Casaretti, R; Manzo, R; Sandomenico, C; Licenziato, M; Avallone, A; Franco, L; on behalf of the Southern Italy Cooperative Oncology, G; [. . ., ]; Roselli, M
Articolo su rivista
01 - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.pdf

accesso aperto

Dimensione 233.9 kB
Formato Adobe PDF
Visualizza/Apri
233.9 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/40317
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact